Implementation of a clinical research "One Signature Initiative" at a large academic medical center.

IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Journal of Clinical and Translational Science Pub Date : 2024-11-29 eCollection Date: 2024-01-01 DOI:10.1017/cts.2024.667
Elizabeth Elin Robison, Trina Lynn Moy, Katelyn Leanna Trigg
{"title":"Implementation of a clinical research \"One Signature Initiative\" at a large academic medical center.","authors":"Elizabeth Elin Robison, Trina Lynn Moy, Katelyn Leanna Trigg","doi":"10.1017/cts.2024.667","DOIUrl":null,"url":null,"abstract":"<p><p>A clinical research team's goal is to support the implementation, conduct, and monitoring of research studies and corresponding protocols. There is a need to ensure that study teams have adequate resources and regulatory support to successfully adhere to regulations and good clinical research practices. Our team, the UC Davis Division of Infectious Diseases Research Unit (IDRU), sought to establish a One Signature Initiative program for all studies and protocols supported by the IDRU. The One Signature Initiative designates one point of contact from each ancillary team or department to sign delegation and training logs, who in turn is delegated to train their team. The goals of the One Signature Initiative were, and are still, to reduce task redundancy, lessen regulatory burden on research teams, and minimize audit findings. Since the implementation of the One Signature Initiative in 2023, acceptance has been favorable, and we have expanded its footprint by incorporating it into our standard operating procedures. This article discusses our experiences, and ancillary departments' experiences, with the One Signature Initiative. Our experience is an example of how a One Signature Initiative can be developed that is efficient, effective, and well-accepted by clinical research stakeholders.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"8 1","pages":"e221"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11713423/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/cts.2024.667","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

A clinical research team's goal is to support the implementation, conduct, and monitoring of research studies and corresponding protocols. There is a need to ensure that study teams have adequate resources and regulatory support to successfully adhere to regulations and good clinical research practices. Our team, the UC Davis Division of Infectious Diseases Research Unit (IDRU), sought to establish a One Signature Initiative program for all studies and protocols supported by the IDRU. The One Signature Initiative designates one point of contact from each ancillary team or department to sign delegation and training logs, who in turn is delegated to train their team. The goals of the One Signature Initiative were, and are still, to reduce task redundancy, lessen regulatory burden on research teams, and minimize audit findings. Since the implementation of the One Signature Initiative in 2023, acceptance has been favorable, and we have expanded its footprint by incorporating it into our standard operating procedures. This article discusses our experiences, and ancillary departments' experiences, with the One Signature Initiative. Our experience is an example of how a One Signature Initiative can be developed that is efficient, effective, and well-accepted by clinical research stakeholders.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在某大型学术医疗中心实施临床研究“一个签名倡议”。
临床研究团队的目标是支持研究和相应方案的实施、实施和监测。有必要确保研究团队有足够的资源和监管支持,以成功地遵守法规和良好的临床研究实践。我们的团队,加州大学戴维斯分校传染病研究部门(IDRU),试图为IDRU支持的所有研究和协议建立一个签名倡议计划。一个签名计划从每个辅助团队或部门指定一个联络点来签署授权和培训日志,他们依次被授权培训他们的团队。One Signature Initiative的目标是减少任务冗余,减轻研究团队的监管负担,并最大限度地减少审计结果。自2023年实施“一个签名倡议”以来,各方对该倡议的接受度很高,并将其纳入我们的标准操作程序,扩大了其影响范围。本文讨论了我们的经验,以及辅助部门的经验,一个签名倡议。我们的经验是一个例子,说明如何开发一个高效、有效并被临床研究利益相关者广泛接受的“一个签名倡议”。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Clinical and Translational Science
Journal of Clinical and Translational Science MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
2.80
自引率
26.90%
发文量
437
审稿时长
18 weeks
期刊最新文献
Using technology to increase reach and optimize consent experience for a large-scale research program. Evaluating translational science knowledge gains following an online short course for a general scientific audience. Health impacts of a remotely delivered prolonged nightly fasting intervention in stressed adults with memory decline and obesity: A nationwide randomized controlled pilot trial - ADDENDUM. The changing demographics and severity in hospitalized patients across COVID-19 variants: A national cohort study. A pilot randomized controlled trial of the iPeer2Peer program in adolescents with sickle cell disease: A mixed method study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1